These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 18262729)

  • 21. Abnormal histone modification patterns in lupus CD4+ T cells.
    Hu N; Qiu X; Luo Y; Yuan J; Li Y; Lei W; Zhang G; Zhou Y; Su Y; Lu Q
    J Rheumatol; 2008 May; 35(5):804-10. PubMed ID: 18398941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM; Taher TE; Isenberg DA; Mageed RA
    Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-17 and the Th17 lineage in systemic lupus erythematosus.
    Garrett-Sinha LA; John S; Gaffen SL
    Curr Opin Rheumatol; 2008 Sep; 20(5):519-25. PubMed ID: 18698171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus.
    Urquizu-Padilla M; Balada E; Cortés F; Pérez EH; Vilardell-Tarrés M; Ordi-Ros J
    J Rheumatol; 2009 May; 36(5):953-60. PubMed ID: 19332622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with testosterone or estradiol in melatonin treated females and males MRL/MpJ-Faslpr mice induces negative effects in developing systemic lupus erythematosus.
    Jimenez-Caliani AJ; Jimenez-Jorge S; Molinero P; Rubio A; Guerrero JM; Osuna C
    J Pineal Res; 2008 Sep; 45(2):204-11. PubMed ID: 18507713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [X chromosome inactivation and reactivation during mouse development].
    Amakawa Y; Sado T
    Tanpakushitsu Kakusan Koso; 2008 Jun; 53(7):830-5. PubMed ID: 18536345
    [No Abstract]   [Full Text] [Related]  

  • 29. Decreased recent thymus emigrant number is associated with disease activity in systemic lupus erythematosus.
    Vieira QF; Kayser C; Kallas EG; Andrade LE
    J Rheumatol; 2008 Sep; 35(9):1762-7. PubMed ID: 18634155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of iNKT cells in the immunopathology of systemic lupus erythematosus.
    Gabriel L; Morley BJ; Rogers NJ
    Ann N Y Acad Sci; 2009 Sep; 1173():435-41. PubMed ID: 19758183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The long and the short of it: RNA-directed chromatin asymmetry in mammalian X-chromosome inactivation.
    Kanduri C; Whitehead J; Mohammad F
    FEBS Lett; 2009 Mar; 583(5):857-64. PubMed ID: 19302783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic benefit of treatment with anti-thymocyte globulin and latent TGF-beta1 in the MRL/lpr lupus mouse model.
    Kaplan J; Woodworth L; Smith K; Coco J; Vitsky A; McPherson J
    Lupus; 2008 Sep; 17(9):822-31. PubMed ID: 18755864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
    Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
    Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vitro radiosensitivity in patients with systemic lupus erythematosus.
    Carrillo-Alascio PL; Sabio JM; Núñez-Torres MI; López E; Muñoz-Gámez JA; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
    Lupus; 2009 Jun; 18(7):645-9. PubMed ID: 19433466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus.
    Pan HF; Ye DQ; Li XP
    Nat Clin Pract Rheumatol; 2008 Jul; 4(7):352-3. PubMed ID: 18477998
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.
    Hahn BH; Anderson M; Le E; La Cava A
    Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is X chromosome inactivation a cause or effect of SLE?
    Scofield RH; Lewis VM
    Nat Rev Rheumatol; 2024 Oct; 20(10):599-600. PubMed ID: 39223392
    [No Abstract]   [Full Text] [Related]  

  • 38. Childhood systemic lupus erythematosus in Sultanate of Oman: demographics and clinical analysis.
    Abdwani R; Rizvi SG; El-Nour I
    Lupus; 2008 Jul; 17(7):683-6. PubMed ID: 18625643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of cytosine methylation on ultraviolet-induced cyclobutane pyrimidine dimer formation in genomic DNA.
    Rochette PJ; Lacoste S; Therrien JP; Bastien N; Brash DE; Drouin R
    Mutat Res; 2009 Jun; 665(1-2):7-13. PubMed ID: 19427505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical image: Lupus erythematosus cells in ascites fluid.
    Krug U; Buchner T; Fassbinder T; Gaubitz M; Berdel WE
    Arthritis Rheum; 2009 Mar; 60(3):859. PubMed ID: 19248094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.